Advertisement
Diagnostics
Subscribe to Diagnostics
View Sample

FREE Email Newsletter

US Demand for Drug Delivery Products to Reach $134 Billion in 2015

February 1, 2012 5:34 am | News | Comments

US demand for drug delivery products will expand 7.4 percent annually to $134 billion in 2015. The best growth opportunities will emerge in dosage formulations that advance the nature of therapy for autoimmune conditions, cancer, heart disease, neurological disorders...

Singapore Scientists Lead in 3D Mapping of Human Genome to Help Understand Human Diseases

February 1, 2012 5:20 am | News | Comments

Singapore - (ACN Newswire) - Genome Institute of Singapore's (GIS) Associate Director of Genomic Technologies, Dr Yijun RUAN, led a continuing study on the human genome spatial/structural configuration, revealing how genes interact/communicate and influence each other, even when...

Roche Receives FDA Clearance for Test to Screen and Diagnose Chlamydia and Gonorrhea Infection in Symptomatic and Asymptomatic Patients

February 1, 2012 5:15 am | News | Comments

PLEASANTON, Calif./PRNewswire/ -- Roche announced today that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance to the cobas® CT/NG Test for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections in both symptomatic...

Advertisement

Fourth German Hospital Selects IntraOp Medical Corporation's Mobetron

January 31, 2012 6:04 am | News | Comments

SUNNYVALE, Calif.--(BUSINESS WIRE)--IntraOp Medical Corporation today announced that Helios Berlin Buch became the fourth German hospital and the nineteenth European hospital to purchase a Mobetron for Intra-Operative Electron Radiation Therapy (IOERT).

Capital Health Will be First in U.S. to Offer GE Molecular Breast Imaging

January 31, 2012 5:50 am | News | Comments

HOPEWELL TOWNSHIP, N.J. & WAUKESHA, Wis.--(BUSINESS WIRE)--Capital Health and GE Healthcare announced today the first Discovery NM 750b was installed at Capital Health's New Jersey Hopewell medical center. Capital Health is a central New Jersey region leader in advanced medicine...

TomTec introduces 2D Cardiac Performance Analysis MR its software solution for cardiac MR to analyze myocardial function and deformation

January 31, 2012 5:39 am | News | Comments

MUNICH--(BUSINESS WIRE)--At the upcoming SCMR meeting in Orlando Florida at February 2nd -5th TomTec introduces its 2D Cardiac Performance Analysis© MR software product*. The tool to quantify myocardial function and deformation based on regular cardiac MRI cine imaging.

Bluetooth Innovator of the Year 2011 Honored at ISPO Munich

January 31, 2012 5:33 am | News | Comments

MUNICH--(BUSINESS WIRE)--The Bluetooth Special Interest Group (SIG) today announced Guilherme de Paula from Pancreum, LLC as the Bluetooth Innovator of the Year for 2011. Pancreum's CoreMD design was selected by an expert panel based on the most innovative use of Bluetooth...

Company Brings Cancer Detection Test, Jobs to Hershey

January 31, 2012 5:31 am | News | Comments

HERSHEY, Pa.--(BUSINESS WIRE)--Hershey Center for Applied Research (HCAR) prepares to welcome another international company to its thriving research facility. Based in Dunedin, New Zealand, Pacific Edge Diagnostics, Ltd., a leading developer of cancer diagnostic and prognostic...

Advertisement

Nanotronics Imaging Introduces Its Technology to Medical Research Field

January 31, 2012 5:17 am | News | Comments

New York (MMD Newswire) -- Nanotronics Imaging, a pioneer in nano-inspection for semiconductors, announced today that it will assist medical research by applying its groundbreaking inspection methods to neuroscience, regenerative medicine and other life science fields.

Thermo Fisher Scientific PCT Assay for Sepsis Available for Abbott Analyzers

January 30, 2012 5:32 am | News | Comments

WALTHAM, Mass. – Thermo Fisher Scientific, the world leader in serving science, today announced an agreement with global healthcare provider Abbott Laboratories to make its Procalcitonin (PCT) assay available with Abbott's immunochemistry analyzers.

Market For Mobile Healthcare Applications Will Grow To US$ 1.3 billion in 2012

January 30, 2012 5:30 am | News | Comments

The smartphone application market for mobile healthcare will reach US$ 1.3 billion in 2012 – up from US$ 718 million in 2011. Despite this substantial growth, the mHealth market is still in an embryonic state – especially in comparison to the US$ 6 trillion of the overall global healthcare market.

US Diagnostic Electrocardiography Device Market to Grow at a Slow Rate of 1.5 Percent Through 2016

January 27, 2012 4:50 am | News | Comments

TORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, declining demand in private practices for diagnostic electrocardiography (ECG) devices will contribute to slow growth in the United States market...

CardioComm Solutions, Inc. Passes Canadian Medical Devices Conformity Assessment System ISO 13485:2003 Audit

January 26, 2012 6:05 am | News | Comments

TORONTO--(BUSINESS WIRE)--CardioComm Solutions, Inc., received confirmation from the Canadian Medical Devices Conformity Assessment System (CMDCAS) that it had cleared an ISO audit performed by DQS Medizinprodukte GmbH. CardioComm Solutions is registered...

Advertisement

Fenwal Receives New Regulatory Clearances for Amicus Separator and DXT Relay Software

January 26, 2012 5:47 am | News | Comments

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fenwal Inc., a global medical technology company focused on improving blood separation, collection, safety and availability, announced today it has received clearances from the U.S. Food and Drug Administration to market the Fenwal Amicus® separator...

BIOTRONIK Successfully Completes Testing of BIOTRONIK EHR DataSync— Connecting BIOTRONIK Home Monitoring to Electronic Health Record Systems

January 26, 2012 5:45 am | News | Comments

LAKE OSWEGO, Ore.--(BUSINESS WIRE)--BIOTRONIK, a worldwide leader in manufacturing cardiac medical devices and pioneer of remote patient management solutions, today announced it has successfully completed its final interoperability testing process for BIOTRONIK Home Monitoring®...

Spectranetics Strengthens Peripheral Vascular Portfolio with a Partnership to Distribute the TAPAS Catheter

January 25, 2012 5:42 am | News | Comments

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation today announced an agreement with ThermopeutiX, Inc. to commercialize the TAPAS catheter, a therapeutic infusion system. The product has recently received U.S. Food and Drug Administration (FDA) 510(k) clearance...

Zogenix and Battelle to Collaborate on Advanced Drug Delivery Technology

January 25, 2012 5:32 am | News | Comments

The companies have signed a Letter of Intent to enter into an exclusive co-marketing and technology development option agreement to utilize Zogenix's DosePro® needle-free drug delivery technology for new commercial out-licensing opportunities. DosePro technology enables...

Ukraine Fortifies Cancer Management Capabilities with New Elekta Technology

January 25, 2012 5:10 am | News | Comments

KYIV, Ukraine /PRNewswire/ -- The Rinat Akhmetov (Development of Ukraine) Foundation took bold strides in 2011 to advance patient care by acquiring a comprehensive range of cancer management technology to equip the radiotherapy department at Rivne Regional Oncologic Dispensary in Ukraine.

PMD Healthcare Launches Spiro PD—The First Personal Spirometer to Monitor Lung Function

January 24, 2012 5:26 am | News | Comments

ALLENTOWN, PENNSYLVANIA -- PMD Healthcare Inc., announced today the launch and availability of its novel new lung health monitoring device – Spiro PD. Recently cleared by the U.S. Food and Drug Administration (FDA), Spiro PD is the first and only personal spirometer...

Guided Therapeutics Submits CE Mark Approval Application for LuViva Advanced Cervical Scan

January 24, 2012 4:50 am | News | Comments

NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. today announced that it has submitted the application for CE Mark approval for LuViva® Advanced Cervical Scan. The CE Mark is required to market LuViva in the 27 nations that comprise the European Union (EU).

CardioComm Solutions, Inc. Receives FDA Clearance to Market First Over-the-Counter Heart Monitoring Solution

January 23, 2012 5:44 am | News | Comments

TORONTO--(BUSINESS WIRE)--CardioComm Solutions, Inc., a global medical provider of ECG acquisition and management software solutions, received clearance from the Food and Drug Administration (FDA) for over-the-counter (OTC) sales and marketing of their consumer-based...

Precision Pulmonary Diagnostics to Offer OSA Portable Monitor Testing

January 23, 2012 5:42 am | News | Comments

HOUSTON--(BUSINESS WIRE)--Precision Pulmonary Diagnostics (PPD®) recently added portable monitor testing to its diagnostic offerings of sleep apnea in commercial drivers. PPD is an industry leader, providing turn-key sleep apnea disease management program and lab network.

Medgenics' Receives Allowance for Key European Patent

January 23, 2012 5:30 am | News | Comments

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that the Company received notice of ‘Intention to Grant'...

Guided Therapeutics Provides Update on PMA Application for LuViva Advanced Cervical Scan and Timing for Filing of CE Mark

January 23, 2012 5:27 am | News | Comments

NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. today announced that the company plans to seek an independent panel review of its Pre-market Approval (PMA) application for the LuViva® Advanced Cervical Scan from the U.S. Food and Drug Administration (FDA)...

Alere rapid flu test receives CLIA waiver from FDA

January 23, 2012 5:07 am | News | Comments

Waltham, Massachusetts – Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, received confirmation that The U.S. Food and Drug Administration (FDA) has cleared the Alere™ Influenza A&B Test...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading